Nkarta, Inc. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-05
What changed in the last 30 days
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
| Phase 1 | 2 | |
| Phase 1/2 | 2 |
Disease areas by active trials, top 10 of 11
Leukemia (2) · Acute Lymphoblastic Leukemia (ALL) (1) · Acute Myeloid Leukemia (AML) (1) · Chronic Lymphocytic Leukemia (CLL) (1) · DLBCL (1) · Lupus (SLE) (1) · Mantle Cell Lymphoma (1) · Myelodysplastic Syndromes (MDS) (1) · Non-Hodgkin Lymphoma (1) · Rheumatoid Arthritis (1)
Get alerts when Nkarta, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.